Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers. - Petrice M. Cogswell; Heather J. Wiste; Matthew L. Senjem; Jeffrey L. Gunter; Stephen D. Weigand; Christopher G. Schwarz; Arvin Arani; Terry M. Therneau; Val J. Lowe; David S. Knopman; Hugo Botha; Jonathan Graff-Radford; et al. (NeuroImage, 2021)

CSF dynamics as a predictor of cognitive progression. - Petrice M. Cogswell; Stephen D. Weigand; Heather J. Wiste; Jeffrey L. Gunter; Jonathan Graff-Radford; David T. Jones; Christopher G. Schwarz; Matthew L. Senjem; David S. Knopman; Ronald C. Petersen; Clifford R. Jack Jr. (NeuroImage, 2021)

Changing the face of neuroimaging research: Comparing a new MRI de-facing technique with popular alternatives. - Christopher G. Schwarz; Walter K. Kremers; Heather J. Wiste; Jeffrey L. Gunter; Prashanthi Vemuri; Anthony J. Spychalla; Kejal Kantarci; Aaron P. Schultz; Reisa A. Sperling; David S. Knopman; Ronald C. Petersen; Clifford R. Jack Jr. (NeuroImage, 2021)

Response to "On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021". - Petrice M. Cogswell; Heather J. Wiste; Stephen D. Weigand; Terry M. Therneau; Clifford R. Jack Jr. (NeuroImage, 2022)